In vivo cell cloning accomplished through in vitro cell culture is one of the novel solutions providing methods in today’s science-based progress. Concurrently, the application of AI technology in regenerative medicine production has revolutionized the modern medical industry and biotechnological research. Emerging as a breakthrough solution, 3D cell culture models cultured to mimic cellular or organ reaction to specific situations is the newest trend attributing to the growth of cell culture market demand across the globe. Drug testing for cancer, viral diseases, and ageing-related morbidity and toxicology of certain products are successfully transforming the chain of antibodies, protein, vaccines, and other genetic engineering productions pushing forth the global cell culture market. Monoclonal antibodies and immortalized cell line development are penetrating various medical researches inflicting better results in gene therapy. Consequently, this mechanism is acquiring huge demand thereby elevating the cell culture market growth. For instance, the cultured meat, produced in labs through the in vitro process, has revolutionized the livestock agriculture industry. Significantly, this development will stimulate the niche market demand in the forthcoming years. Recent research was conducted to culture skin keratinocytes by nurturing vital tissue proteins in vitro technique. This novel procedure is claimed to provide treatment for burn wounds and other skin related deformities. The unique and innovative skin grafting procedure introduced by the Duke-NUS Medical School and the Singapore General Hospital (SGH) is a major breakthrough study that will upheave the cell culture industrial progress gradually. With the emergence of several developments and innovations, the global cell culture market will generate huge economic profit in the forthcoming years. Significantly, this market is estimated to grow at a CAGR of 10.7% during the forecast period of 2019-2025. Also, the global cell culture market gained a revenue of $14.14 billion in the year 2018.

Offering breakthrough innovation in drug discovery and testing, cell culture plays a vital role in the biopharmaceutical industry. Novel biopharmaceuticals innovations are produced through the genetic manipulation of mammalian cells. This process accompanies subsequent administration of drug properties and cellular reactions thereby relying on cell culture technology. For instance, monoclonal antibodies, recombinant proteins, and other biologics products derived from animals are the most common biopharmaceutical products utilized in the medical industry. Furthermore, the manufacturing of these products requires a huge dependency on cell culture procedures. Consequently, the biopharmaceutical industry generates huge demand for the cell culture market which is anticipated to increase at a considerable CAGR of 11.2% through to 2025.

North America is dominating the global cell culture market and contributed a major regional share of 33% as of 2018. This prospect is propelled by regular government initiatives for providing better healthcare facilities and increasing inclination towards technological advancements. Recently, Bayer invested $150 million for building a cell culture technology center in California, the U.S.A. which will facilitate cardiology, oncology, and other therapeutics research studies. Also, the federal government and the National Institutes of Health (NIH) is spending a huge amount of resources for effective medical and health R&D. The NIH invested around $1,824 million as of 2018 for stem cell studies and $39.2 billion annually on other medical research for the healthcare progress of the Americans. This reflects the immense growth prospect of the cell culture market in North America owing to the massive expenditure on medical studies. As a result, the resultant developments will gravitate to the domestic cell culture market towards advancement.

Investments In Cell Culture Technology:

Currently, several governmental organizations and private sector companies are funding humongously on genomic studies and tests on cellular reactions to a particular medication or vaccinations, which makes cell culture a highly reliant solution in modern healthcare industry. For instance, LabCorp resourced $3 million to Kiyatec to boost the 3D cell culture researches on cancer treatment and Fujifilm invested $130 million to expand the biopharma contract development manufacturing operation in the U.S. and U.K. to drive mammalian cell culture studies and development in emerging solutions. With the advent of Agriculture 2.0 in the global market, analysis on new cultures has aided the manufacturing of cultured meat which is the newest trend revolutionizing agribusiness throughout the world. Emerging country like India is capitalizing largely in this novel cell culture development to minimize the dependency on the livestock slaughtering for meat. The Government of India’s Department of Biotechnology (DBT) funded $640,000 to the Centre for Cellular and Molecular Biology (CCMB) and National Research Centre on Meat (NRCMeat) in Hyderabad for cultured meat research this year. Furthermore, a German-based multinational pharmaceutical and life science company, Bayer, partners with GE healthcare and Fluor to construct and deploy advanced cell culture technologies in its California branch. Constructively, these investment strategies are likely to boost the global cell culture market thereby experiencing a wide scope of novel prospect in recent years.

Advances and Innovation In Cell Culture Market:

Cell culture technology is supporting the development of regenerative medicine and augmenting the wide dimensional discovery eventually aiding the healthcare advancements consequently elevating the niche market growth prospects and demand generation. Current inclination towards cell-cultured meat production in laboratories and expansion and progression in the 3D cell culture drug discovery through the utilization of stem cells are transforming multifarious bioscience sectors across the globe. Recently, Panasonic introduced an automated cell culture system for the Induced Pluripotent Stem (iPS) cells. This system will eliminate the extensive manual programming and monitoring of cell culture researches, significantly accelerating the innovation of new drugs and medication in the future years. Similar innovations led by Kawasaki’s AUTO CULTURE automated cell processing system are also likely to acquire huge market demand owing to the automation of biotechnological processes which leverages higher efficiency without direct individualistic involvement. Other significant advancements include NanoSurface Cultureware introduced by NanoSurface Biomedical and 3D cell culture chip launched by the AIM Biotech. These novel systems and technologies are expediting the global cell culture market growth thereby enhancing the modern medical approach towards precision medicine.

Rising Demand Through Diverse Applications:

The rise in adoption of cell culture technology in modern medicine and biomedical experiments reduces the need for animal studies. Also with emerging technology, the efficacy of conducting complex experimentations offers promising solutions for chronic diseases, ageing and related comorbidity, and other bodily abnormalities. According to the Cancer Research U.K., nearly 17 million cancer cases were recorded in 2018. This is likely to develop newer vaccination, drugs, and immunization treatment procedures resultantly, upheaving the global cell culture market demand.

Around 16,452 genes were tested as of 2018 and approximately 18,653 gene tests will be conducted in the year 2019.

- National Center for Biotechnology Information

Although the rise in genetic disorders increases the risk of transference of psychological and physical impairments from parent species to fetuses, through modern genetic counselling procedures this can be successfully reduced through active cell culture and development researches. Additionally, the study of cytotoxicity after drug discovery requires cell culture analysis which heightens its demand in the global market. Correspondingly, other applications segments such as virology testing and vaccine production, tissue replacement in burn and ulcer patients and commercial genetic testing are highly reliant on the cell culture procedure which is imperative to biomedical R&D to increase life expectancy and eliminate the risk of diseases.

Major Players In The Cell Culture Market:

The global cell culture market is experiencing extensive growth which is hastened by the innovative approaches and launches introduced by several pioneering companies such as Thermo Fisher Scientific, The Merck Group, GE Healthcare, Lonza Group, Becton, Dickinson and Company, Corning Incorporated, Eppendorf, HiMedia Laboratories Pvt. Ltd., The Sartorius group and Invivogen. Novel ideas and products developed by these companies ascertain progressive prospect of the regenerative medicine and genetic disorder improvement through advanced 3D cell culture systems thereby leveraging huge revenue and contributing massively to the global cell culture market growth.

Lonza Group, a leading multinational chemical and biotechnology company hugely invests and delivers a wide range of cell culture products and technology-induced development to boost the cellular and pharmaceutical research study. Its major contribution to the cell culture market includes RAFT™ 3D Cell Culture System and Quasi Vivo® 3D Cell Culture System to produce 3D models for promoting cell line construction, monoclonal antibodies and other genetically engineered protein development.

Talk to one of our sales representative about the full report by providing your details in the link below:

Related Reports:

A.    Cell Line Development Market

B.     Cell Lysis/Cell Fractionation Market

C.    Regenerative Medicine Market

Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

To request for a quote, provide your details in the below link:

Media Contact:

Mr. Venkat Reddy

Sales Manager         

Email: [email protected]

Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.